Paez-Pereda, M.; Kuchenbauer, F.; Arzt, E.; Stalla, G. K.: Regulation of pituitary hormones and cell proliferation by components of the extracellular matrix. Brazilian Journal of Medical and Biological Research 38 (10), S. 1487 - 1494 (2005)

Reilmann, R.; Kirsten, F.; Bohlen, S.; Saemann, P.; Merl, T.; Auer, D.; Klopstock, T.; Bender, A.; Dose, M.; Weindel, A. et al.; Ringelstein, E. B.: Multimodal objective assessment of motor deficits in Huntington's disease using isometric force analysis. Journal of Neurology Neurosurgery and Psychiatry 76 (Suppl. 4) (2005)

Schredl, M.; Fulda, S.: Dream recall and sleep duration: State or trait factor. Perceptual and Motor Skills 101 (2), S. 613 - 616 (2005)

Schüle, C.; Baghai, T. C.; Alajbegovic, L.; Schwarz, M.; Zwanzger, P.; Eser, D.; Schaaf, L.; Möller, H. J.; Rupprecht, R.: The influence of 4-week treatment with sertraline on the combined T3/TRH test in depressed patients. European Archives of Psychiatry and Clinical Neuroscience 255 (5), S. 334 - 340 (2005)

Torok, H. P.; Glas, J.; Tonenchi, L.; Lohse, P.; Müller-Myhsok, B.; Limbersky, O.; Neugebauer, C.; Schnitzler, F.; Seiderer, J.; Tillack, C. et al.; Brand, S.; Brunnler, G.; Jagiello, P.; Epplen, J. T.; Griga, T.; Klein, W.; Schiemann, U.; Folwaczny, M.; Ochsenkuhn, T.; Folwaczny, C.: Polymorphisms in the DLG5 and OCTN cation transporter genes in Crohn's disease. Gut 54 (10), S. 1421 - 1427 (2005)

Wittchen, H. U.: The size and burden of mental disorders in Europe - an ECNP task force report. European Neuropsychopharmacology 15 (Suppl. 3), S. S313 - S313 (2005)

Kalisch, R.; Schubert, M.; Jacob, W.; Keßler, M. S.; Hemauer, R.; Wigger, A.; Landgraf, R.; Auer, D.: Anxiety and hippocampus volume in the rat. Neuropsychopharmacology 31 (5), doi: 10.1038/sj.npp.1300910, S. 925 - 932 (2005)

Barden, N.; Harvey, M.; Gagne, B.; Raymond, C.; Labbe, M.; Müller-Myhsok, B.; Binder, E.; Holsboer, F.: A glutamine to arginine mutation in the C-terminal domain of P2RX7 determines the risk for mood disorders. American Journal of Medical Genetics Part B-Neuropsychiatric Genetics 138B (1), S. 82 - 82 (2005)

Erhardt, A.; Seaman, S. R.; Lucae, S.; Unschuld, P. G.; Kern, N.; Welt, T.; Ising, M.; Salyakina, D.; Pütz, B.; Lieb, R. et al.; Binder, E.; Müller-Myhsok, B.; Holsboer, F.; Keck, M. E.: Genetic implications of the endocannabinoid system in anxiety disorders versus depressive disorders: Is there any evidence for the continuum hypothesis? American Journal of Medical Genetics Part B-Neuropsychiatric Genetics 138B (1), S. 44 - 44 (2005)

Horstmann, S.; Ising, M.; Lucae, S.; Kloiber, S.; Dose, T.; Salyakina, D.; Pütz, B.; Uhr, M.; Müller-Myhsok, B.; Holsboer, F.: The cortisol and ACTH response in the combined Dex/CRH test of acutely depressed patients varies significantly between 5-HT2A receptor genotypes. American Journal of Medical Genetics Part B-Neuropsychiatric Genetics 138B (1), S. 48 - 48 (2005)

Kern, N.; Erhardt, A.; Pfennig, A.; Lucae, S.; Ising, M.; Salyakina, D.; Pütz, B.; Müller-Myhsok, B.; Uhr, M.; Holsboer, F. et al.; Binder, E. B.; Keck, M. E.: Syndromal panic attacks are possibly associated with polymorphisms in the angiotensin converting enzyme (ACE) gene. American Journal of Medical Genetics Part B-Neuropsychiatric Genetics 138B (1), S. 45 - 45 (2005)

Prokopenko, I.; Tozzi, F.; Perry, J. D.; McCarthy, A. D.; Chissoe, S. L.; St Jean, P. L.; Alalouff, S.; Brewster, S. R.; Kennedy, J. L.; Middleton, L. T. et al.; Holsboer, F.; Muglia, P.: Major depressive disorder: Identifying phenotypic subtypes for genetic studies. American Journal of Medical Genetics Part B-Neuropsychiatric Genetics 138B (1), S. 107 - 107 (2005)

Baghai, T. C.; Binder, E. B.; Holsboer, F.; Rupprecht, R.; Bondy, B.: Polymorphisms in the angiotensin converting enzyme (ACE) gene are associated with unipolar depression, ACE activity and hypercortisolism. Pharmacopsychiatry 38 (5), S. 228 - 228 (2005)

Beitinger, P. A.; Dalal, M. A.; Wehrle, R.; Fulda, S.; Schuld, A.; Wetter, T. C.; Pollmächer, T.: Impaired glucose tolerance in patients with narcolepsy. Pharmacopsychiatry 38 (5), S. 230 - 230 (2005)

Breu, J.; Deussing, J. M.; Wurst, W.: CRHR-1 signalling inhibits AMPA-receptor internalisation. Pharmacopsychiatry 38 (5), S. 232 - 232 (2005)

Bschor, T.; Ritter, D.; Lewitzka, U.; Bauer, M.; Adli, M.; Baethge, C.; Uhr, M.; Ising, M.: Effects of lithium on the HPA axis in patients with unipolar major depression. Pharmacopsychiatry 38 (5), S. 233 - 234 (2005)

Capasso, R.; Matias, I.; Lutz, B.; Borrelli, F.; Capasso, F.; Marsicano, G.; Mascolo, N.; Petrosino, S.; Monory, K.; Valenti, M. et al.; Di Marzo, V.; Izzo, A. A.: Fatty acid amide hydrolase controls mouse intestinal motility in vivo. Gastroenterology 129 (3), S. 941 - 951 (2005)

Cerqueira, J. J.; Catania, C.; Sotiropoulos, I.; Schubert, M.; Kalisch, R.; Almeida, O. F. X.; Auer, D. P.; Sousa, N.: Corticosteroid status influences the volume of the rat cingulate cortex - a magnetic resonance imaging study. Journal of Psychiatric Research 39 (5), S. 451 - 460 (2005)

Czibere, L.; Kessler, M. S.; Birg, I.; Panhuysen, M.; Pütz, B.; Deussing, J. M.; Turck, C. W.; Landgraf, R.: Glyoxalase I: Implications for an enzyme involved in trait anxiety. Pharmacopsychiatry 38 (5), S. 235 - 235 (2005)

Deussing, J. M.; Kühne, C.; Panhuysen, M.; Pütz, B.; Breu, J.; Paez-Pereda, M.; Holsboer, F.; Wurst, W.: Gene expression profiling reveals corticotropin-releasing hormone (CRH) dependent signaling pathways. Pharmacopsychiatry 38 (5), S. 236 - 236 (2005)